DM-Flow/Trio
ANS/DPN/PAD
Diabetes 3 Devices (6 billing codes)
The DM Flow/Trio are three (3) individual and evidence-based FDA Cleared modalities that identify and measure the autonomic nervous system (ANS), diabetic peripheral neuropathy (DPN), and peripheral arterial disease (PAD).
Statistically Significant Reductions
Features of the tests:
Non-Invasive
3-minutes or less each to complete
FDA Cleared with recommended billing codes
Easy to interpret color-coded reports
Allows provider to perform and bill for up to 6 billing codes
3 Test with 6 Billing Codes
The DM Flow/Trio are three (3) individual medical devices with three (3) individual reports (as required by CMS) with the following features:
Measurement of Peripheral Artery Disease (PAD)
Measurement of the Sympathetic Skin Response (SSR) for the sudomotor function testing (small fiber)
Measurement of the Sympathetic Skin Response (SSR) for the loss of protective sensation (large fiber)
Measuring the Autonomic Nervous System (ANS) via Heart Rate Variability
Both Diabetic Foot Exams are Reimbursable by Medicare
1. Diabetic Neuropathy Device™ www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies and Measures Peripheral Neuropathy.
Identify Heart Attacks and Strokes Early
2. Autonomic Nervous System (ANS) www.ANStest.org device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.
Prevent Lower-Extremity Amputations
3. TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow.
Major Causes
- Diabetes
- High Blood Pressure
- Smoking History
- High Cholesterol
Get Tested If
- You have DM
- Over age 65
- Over age 50 and have a history of diabetes or smoking
- Under age 50, but have diabetes and other PAD risk factors, such as obesity or high BP
Competitive Advantages
- Individual Exams and Reports
